Science Explorer Back to mapMap
Discussion
Researcher · Rocky Mountain Cancer Centers · United States

Manojkumar Bupathi

Manojkumar Bupathi publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Surgery, on topics such as Bladder and Urothelial Cancer Treatments, Cancer Immunotherapy and Biomarkers and Renal cell carcinoma treatment.

ORCID 0009-0003-5613-3283 OpenAlex
World rank
#1,559,685
of 7,710,434 ranked researchers
Rank in United States
#486,655
of 1,627,098
Works
92
Citations
1.4k
Citations per work
15.2
h-index
18
i10-index 28Top 28% in Oncology
Manojkumar Bupathi

What does Manojkumar Bupathi research?

Manojkumar Bupathi's work is mostly in Medicine (65%), Biochemistry, Genetics and Molecular Biology (10%).

Health Sciences: 59 works · 64.6% of their workMedicine: 59 works · 64.6% of their workOncology: 21 works · 22.9% of their workPulmonary and Respiratory Medicine: 19 works · 20.4% of their workSurgery: 16 works · 17.1% of their workEpidemiology: 4 works · 4.2% of their workEverything else: 23 works · 25.4% of their workLife Sciences: 9 works · 10.0% of their workBiochemistry, Genetics and Molecular Biology: 9 works · 10.0% of their workCancer Research: 5 works · 5.0% of their workMolecular Biology: 5 works · 5.0% of their workTHEIR WORKManojkumarBupathi92works
Life Sciences10%Health Sciences65%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine5964.6%
  2. Everything else2325.4%
    1. Biochemistry, Genetics and Molecular Biology910.0%
  1. 1Oncology23% of their works
  2. 2Pulmonary and Respiratory Medicine20% of their works
  3. 3Surgery17% of their works
  4. 4Molecular Biology5% of their works
  5. 5Cancer Research5% of their works
  6. 6Epidemiology4% of their works

Research topics

Which keywords describe Manojkumar Bupathi's research?

The keywords of their largest research topics: Immunotherapy, Molecular Characterization, Chemotherapy, Bladder Cancer, Genetic Mutations, Urothelial Carcinoma, Immune Checkpoint Blockade and PD-1 and PD-L1.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 20 words, with their numbers
  1. Immunotherapy583 topics
  2. Molecular Characterization452 topics
  3. Chemotherapy362 topics
  4. Bladder Cancer291 topic
  5. Genetic Mutations292 topics
  6. Urothelial Carcinoma291 topic
  7. Immune Checkpoint Blockade251 topic
  8. PD-1 and PD-L1251 topic
  9. Metastatic161 topic
  10. Renal Cell Carcinoma161 topic
  11. Androgen Receptor131 topic
  12. Prostate Cancer131 topic
  13. Multiple Primary Cancers91 topic
  14. Second Primary Neoplasms91 topic
  15. Primary Urethral Carcinoma81 topic
  16. Urachal Carcinoma81 topic
  17. Cetuximab71 topic
  18. KRAS Mutations71 topic
  19. Chemotherapy-Induced Peripheral Neuropathy61 topic
  20. Taxanes61 topic

Where does Manojkumar Bupathi work?

Manojkumar Bupathi's main affiliation in the publication record is Rocky Mountain Cancer Centers, United States.

How many publications and citations does Manojkumar Bupathi have?

OpenAlex counts 92 works and 1,400 citations for Manojkumar Bupathi, an h-index of 18, ranking #1,559,685 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Manojkumar Bupathi. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.